|
Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis
RECRUITINGN/ASponsored by University of Pennsylvania
Actively Recruiting
PhaseN/A
SponsorUniversity of Pennsylvania
Started2023-06-15
Est. completion2026-06
Eligibility
Age40 Years – 75 Years
Healthy vol.Accepted
Locations10 sites
View on ClinicalTrials.gov →
NCT05908240
Summary
The goal of this research is to test a novel centralized care coordinator program to assist patients with psoriatic disease in lowering their risk of cardiovascular disease through the application of standard of care approaches to improving modifiable cardiovascular risk factors.
Eligibility
Age: 40 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria: 1. Willing and able to provide informed consent 2. Male or female aged 40-75 3. Being seen by a dermatology provider in routine care for the primary encounter diagnosis of psoriasis Exclusion Criteria: 1. Currently taking a prescription lipid lowering medication 2. Pregnant or planning pregnancy in the next 6 months 3. Has a known history of cardiovascular disease (MI, Stroke, coronary artery, cerebrovascular, or peripheral vascular disease)
Conditions5
ArthritisCardiovascular DiseasesPsoriasisPsoriatic ArthritisPsoriatic Conditions
Locations10 sites
Johnson Dermatology
Fort Smith, Arkansas, 72916
Karen Garduza
Dawes Fretzin Clinical Research
Columbus, Indiana, 47201
Betty Uyesugi
Dawes Fretzin Clinical Research
Indianapolis, Indiana, 46250
Ashley Wallace
MiSkinCenter
Northville, Michigan, 48167
Jamie Szkodzinski
SUNY Downstate
Brooklyn, New York, 11203
Tristi Edwards
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorUniversity of Pennsylvania
Started2023-06-15
Est. completion2026-06
Eligibility
Age40 Years – 75 Years
Healthy vol.Accepted
Locations10 sites
View on ClinicalTrials.gov →
NCT05908240